Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MPI | P34949 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22412510 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL285568 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL9736991 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL8057 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL3397672 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL9737359 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL187554 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL9737508 | 1.00 | LMNA (0.41) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL2387363 | 0.98 | LMNA (0.39) | LMNAL3MBTL1TDP1MPIPDE4A | |
| SCHEMBL9736985 | 0.98 | TDP1 (0.43) | LMNAL3MBTL1TDP1MPIPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137616-A1 | Skincare Composition Utilizing a Metabolomics Guided, Bioprocess Engineered Sunflower Sprout Active | JAMRM LLC (US) | 2026-05-21 | — | — | US | claimed |
| US-12527734-B2 | Skincare composition utilizing a metabolomics guided, bioprocess engineered sunflower sprout active | JAMRM, LLC (US) | 2026-01-20 | — | — | US | claimed |
| EP-4539818-A1 | SKINCARE COMPOSITION UTILIZING A METABOLOMICS GUIDED, BIOPROCESS ENGINEERED SUNFLOWER SPROUT ACTIVE | Jamrm, LLC (US) | 2025-04-23 | — | — | EP | claimed |
| US-20230404902-A1 | Skincare Composition Utilizing a Metabolomics Guided, Bioprocess Engineered Sunflower Sprout Active | JAMRM, LLC | 2023-12-21 | — | — | US | claimed |
| WO-2023244666-A1 | SKINCARE COMPOSITION UTILIZING A METABOLOMICS GUIDED, BIOPROCESS ENGINEERED SUNFLOWER SPROUT ACTIVE | JAMRM, LLC (US) | 2023-12-21 | — | — | WO | claimed |
| CN-114437209-A | Monoclonal antibody specifically binding to abrin and application thereof | 北京弘进久安生物科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| US-4970156-A | Immobilization of active protein by cross-linking to inactive protein | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (FR) | 1990-11-13 | — | — | US | claimed |
| US-4464468-A | GLUTARALDEHYDE CROSSLINKERS | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1984-08-07 | — | — | US | claimed |
| JP-10195094-A | — | — | None | — | — | JP | disclosed |
| US-20260137616-A1 | Skincare Composition Utilizing a Metabolomics Guided, Bioprocess Engineered Sunflower Sprout Active | JAMRM LLC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12527734-B2 | Skincare composition utilizing a metabolomics guided, bioprocess engineered sunflower sprout active | JAMRM, LLC (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4539818-A1 | SKINCARE COMPOSITION UTILIZING A METABOLOMICS GUIDED, BIOPROCESS ENGINEERED SUNFLOWER SPROUT ACTIVE | Jamrm, LLC (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-118382449-A | Adeno-associated vectors and virosomes for treating galactosylation and methods of use and manufacture | 加格尔基因治疗有限责任公司 | 2024-07-23 | — | — | CN | disclosed |
| US-11891598-B2 | Means and methods for producing phosphate containing capsular polysaccharides | MEDIZINISCHE HOCHSCHULE HANNOVER (MHH) (DE) | 2024-02-06 | — | — | US | disclosed |
| EP-0849992-A1 | DRY SOLID MEDIUM FOR STORAGE AND ANALYSIS OF GENETIC MATERIAL | FLINDERS TECHNOLOGIES PTY. LTD. (AU) | 1998-07-01 | — | — | EP | disclosed |
| US-5756126-A | MIXTURE OF BASE, CHELATE COMPOUND AND ANIONIC DETERGENTABSORBED ON A SOLID MATRIX | FLINDERS TECHNOLOGIES PTY. LTD. (AU) | 1998-05-26 | — | — | US | disclosed |
| WO-1996039813-A1 | DRY SOLID MEDIUM FOR STORAGE AND ANALYSIS OF GENETIC MATERIAL | FLINDERS TECHNOLOGIES PTY. LTD. (AU) | 1996-12-19 | — | — | WO | disclosed |
| US-4970156-A | Immobilization of active protein by cross-linking to inactive protein | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (FR) | 1990-11-13 | — | — | US | disclosed |
| US-4464468-A | GLUTARALDEHYDE CROSSLINKERS | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1984-08-07 | — | — | US | disclosed |
| US-4004979-A | CONTROLLING DEGREE OF CROSSLINKING WITH TRIS(HYDROXYMETHYL) AMINOMETHANE | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137616-A1 | Skincare Composition Utilizing a Metabolomics Guided, Bioprocess Engineered Sunflower Sprout Active | CUTA, CHAMP1, SHMT2 | LMNA 3253/4885L3MBTL1 2412/4885TDP1 2795/4885 |
| US-12527734-B2 | Skincare composition utilizing a metabolomics guided, bioprocess engineered sunflower sprout active | CUTA, SHMT2, SNRK | LMNA 2782/4885L3MBTL1 1899/4885TDP1 2043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.